Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MarketBeat

Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All

As weight loss drugs move from injections to pills, this thematic ETF provides broad exposure for investors looking to profit from the industry’s next leg up.

MarketBeat

3 Data Center Beneficiaries Raising Dividends Up to 60%

Demand from data center build-outs contributed to impressive gains for three stocks in 2025, and now, higher dividends in 2026.

MarketBeat

Insiders Are Selling These 3 High-Flying Stocks

MP Materials, Oklo, and Redwire are seeing enormous insider selling over the last 1-2 months. See what these sales mean for each name.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026

2026 could be a pivotal year for three biotech names, including a standout in the hemodialysis space and two emerging companies with strong pipelines.

MarketBeat

3 “Forever Stocks” to Hold When the Market Won’t Sit Still

Chevron, Colgate-Palmolive, and Merck highlight how dividends, durable businesses, and long-term growth drivers can support a buy-and-hold investment strategy

MarketBeat

3 Innovative Crypto ETFs That May Surprise in 2026

With new approaches to crypto, these ETFs offer benefits including staking, regular distributions, and a focus on lesser-known but important digital assets.

MarketBeat

2 Buffett Stocks to Load Up On—And 1 to Ditch

With Buffett having officially stepped down at Berkshire Hathaway, investors might continue to follow his lead when it comes to these popular names.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Can't Choose Between Silver and Gold? These ETFs Hold Both

Silver and gold broke out over the past year, but analysts believe it’s just the beginning of a bull cycle. These ETFs provide exposure to both precious metals.

MarketBeat

Big Risk, Potentially Bigger Return For These 3 Leveraged ETF's

Three leveraged ETFs—two focused on commodities and a third on FANG+ stocks—may appeal to investors willing to take a risk for outsized returns.

MarketBeat

The 3 Penny Stocks You Swore You’d Never Buy (But You’ll Check Anyway)

Investors can use a free MarketBeat screener to find popular penny stocks; here are three stocks that may offer speculative upside for risk-tolerant investors

MarketBeat

Spotify’s Price Hike: Why Subscribers Will Pay Up

Increasing subscription prices allows Spotify to generate high-margin revenue that flows directly to the bottom line without raising costs.

MarketBeat

The Cloud Computing ETF Every Growth Investor Should Consider

Cloud computing is a ubiquitous term, but the industry is on the verge of its third evolution. This ETF provides exposure for investors looking to capitalize.

MarketBeat

3 Stocks to Avoid as Software Sector Stumbles

Software stocks are struggling as we enter 2026. Can this sector turn it around this year, or do new AI advances spell more trouble for the beleaguered sector?

MarketBeat

3 Elite ETFs for Compound-Focused Investors

Option-overlay ETFs are reshaping income-focused compounding, turning market volatility into double-digit cash flow that can be reinvested for the long term.

MarketBeat

Get all your
news in one place.

100’s of premium titles.
One news app.

MarketBeat

3 Stocks Built for America’s Affordable Housing Reality

Explore three manufactured home stocks that are poised to benefit from America’s housing shortage and rising demand for affordable homes.

MarketBeat

MarketBeat Week in Review – 01/12 - 01/16

Economic data helped stocks move higher as it showed that the Fed's decision on interest rates may not interrupt the bullish case for equities in 2026.

MarketBeat

AbbVie Call Options Spike 2,599%: Tracking the Big Bet

Large institutional investors are positioning for growth as a leading biopharmaceutical firm enters the obesity market and reaches a federal agreement.

MarketBeat

Goldman Sachs Soars on Q4 Post, Strong Investment Banking Outlook

Investment banking giant Goldman Sachs soared in 2025. The company's M&A outlook provides potential for future gains in 2026.

Get all your
news in one place.

100’s of premium titles.
One news app.

MarketBeat

The $56 Billion Draft: Follow TSMC’s CapEx Stream

A capital injection into the semiconductor supply chain creates guaranteed revenue for the companies building the infrastructure of the digital economy.

MarketBeat

Why CrowdStrike’s SGNL Acquisition Matters for CRWD Stock

CrowdStrike’s $740M SGNL deal expands identity security within the Falcon platform as CRWD stock tests support amid valuation concerns

MarketBeat

Small Caps Break Out! Russell 2000 Poised for 40% Gain

Small-cap stocks are on fire in early 2026, poised for double-digit gains by year's end, as economic tailwinds turn into positive feedback loops.

MarketBeat

Pentagon Deal Sends AST SpaceMobile Soaring—Is This the Next Leg Up?

Shares of AST SpaceMobile surged on Friday after the company announced it was rewarded a government contract as part of the Golden Dome project.

MarketBeat

Guidewire’s Buyback Could Be the Clue the Sell-Off Is Ending

Guidewire Software's 2025 stock price correction overextended and set this market up for a robust rebound in 2026: share buybacks and institutions are the key.

MarketBeat

3 Low P/E Stocks: Separating Multibaggers From a Value Trap

Low P/E is the cornerstone of value investing, but it isn't the only metric to watch. Value traps are a risk investors need to avoid.

MarketBeat

3 Metals Stocks Bank of America Is Bullish on for 2026

Bank of America highlights Agnico Eagle, Freeport-McMoRan, and Cameco as mining stocks positioned to benefit from strength in gold, copper, and uranium

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.